EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Stent Patency and Survival after PTBD and Biliary Stenting for Pancreatic Cancer: A 5-Year Retrospective Cohort Study

Yun Tao iD, Jie Tang iD, Wenhui Yu iD, Wenge Yang iD, Meng Zhang iD, Qinghua Wu, Jie Li iD

Archives of Iranian Medicine · 2025

DOI: 10.34172/aim.34988 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Archives of Iranian Medicine, 2025. Verfasst von Yun Tao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Affiliated Hospital of Jiangnan University, 214000, Wuxi, China. Hauptthemen laut MEDLINE: Stents, Pancreatic Neoplasms, Jaundice, Obstructive, Drainage. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obstructive jaundice commonly complicates pancreatic cancer and often requires biliary decompression. Percutaneous transhepatic biliary drainage (PTBD) followed by stent placement is used for palliation, but long-term stent patency and the relationship between patency and overall survival (OS) remain incompletely characterized.

Methods

We conducted a retrospective cohort study of 60 consecutive patients who underwent sequential PTBD and biliary stent placement at the Affiliated Hospital of Jiangnan University (Wuxi, China) between January 2020 and December 2024. Primary endpoint was stent patency (time from stent insertion to radiologically confirmed occlusion or repeat intervention). Secondary endpoint was OS measured from stent insertion. Patient characteristics, stent type (covered vs uncovered), tumor location, stage, and receipt of systemic chemotherapy were extracted from electronic medical records. Kaplan–Meier analysis and Cox proportional hazards models (adjusted for age, sex, cancer stage, tumor location, baseline bilirubin and chemotherapy) were used. Proportional hazards assumption was tested using Schoenfeld residuals.

Results

Median stent patency was 12.0 months (IQR 8.0–15.0) and median OS was 9.5 months (IQR 6.0–13.0). Covered stents were associated with longer patency (median 13.0 vs 11.0 months; log-rank P=0.018). In multivariable Cox regression, Stage IV disease (adjusted HR 2.50; 95% CI 1.68–3.86; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StentsPancreatic NeoplasmsJaundice, ObstructiveDrainageHumansRetrospective StudiesMaleFemaleMiddle AgedAgedProportional Hazards ModelsKaplan-Meier EstimatePalliative Care

Stichwörter der Autor:innen

Biliary stentInterventional radiologyObstructive jaundicePTBDPalliative carePancreatic cancerStent patencySurvival analysis

Autor:innen und Institutionen

  • Department of Interventional Radiology, Affiliated Hospital of Jiangnan University, 214000, Wuxi, China.

ORCID-Profile: Yun Tao, Jie Tang, Wenhui Yu, Wenge Yang, Meng Zhang, Jie Li

Zitieren

APA

Tao, Y., Tang, J., Yu, W., Yang, W., Zhang, M., Wu, Q., & Li, J. (2025). Stent Patency and Survival after PTBD and Biliary Stenting for Pancreatic Cancer: A 5-Year Retrospective Cohort Study. Archives of Iranian Medicine. https://doi.org/10.34172/aim.34988

Vancouver

Tao Y, Tang J, Yu W, Yang W, Zhang M, Wu Q, et al. Stent Patency and Survival after PTBD and Biliary Stenting for Pancreatic Cancer: A 5-Year Retrospective Cohort Study. Archives of Iranian Medicine. 2025. doi:10.34172/aim.34988

BibTeX
@article{Tao2025,
  author = {Tao, Yun and Tang, Jie and Yu, Wenhui and Yang, Wenge and Zhang, Meng and Wu, Qinghua and Li, Jie},
  title = {Stent Patency and Survival after PTBD and Biliary Stenting for Pancreatic Cancer: A 5-Year Retrospective Cohort Study},
  journal = {Archives of Iranian Medicine},
  year = {2025},
  doi = {10.34172/aim.34988}
}
Kostenlos starten →